Will the new corona domestic vaccine be put into practical use again next year? Pharmaceutical companies forecast October 14, 22:16
A symposium in which domestic pharmaceutical companies promoting the development of new coronavirus vaccines will be held in Yokohama on the 14th, and pharmaceutical companies are forecasting that it will be next year when domestic vaccines will be put into practical use. Shown.
This symposium was held as part of a bio-related exhibition, and was attended by five domestic pharmaceutical companies promoting the development of vaccines for the new corona virus, and is a global virus researcher at the Institute of Medical Science, the University of Tokyo. Was moderated by Professor Yoshihiro Kawaoka.
Among them, the person in charge of the pharmaceutical company introduced the features and progress of the vaccine under development, and among them, a venture company in Osaka, which is already conducting clinical trials with a vaccine of a new technology utilizing DNA, said, "Development. If it goes well, mass production will be possible in the second half of 2022. "
In addition, a major pharmaceutical company developing a vaccine using a substance called RNA of a gene explained, "I want to develop it as soon as possible with 2022 in mind."
Then, the person in charge of PMDA = Pharmaceuticals and Medical Devices Agency, which examines domestic drugs, said, "While sharing the concept of efficacy and safety internationally, the developed vaccine is fair regardless of whether it is domestic or overseas. I would like to review it. "